FDA Inspection
UCLA Medical IRB 1 (OHRPP)UCLA Medical IRB 1 (OHRPP) – FDA Inspection, Jun 26, 2019
Record Details
This FDA Inspection record concerns UCLA Medical IRB 1 (OHRPP), with an inspection on June 26, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · be1f6cc8-cd70-476f-994d-5365b9bffb0b
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1094207
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 56.107(c)One scientific and one non-scientific member
Full citation text and observation details available on the Dashboard.
Other FDA inspections of UCLA Medical IRB 1 (OHRPP)
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 4, 2025 | Not classified | Los Angeles District Office | |
| December 10, 2012 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for UCLA Medical IRB 1 (OHRPP)
- FDA Inspection 1273458 - 2025-06-04
- FDA Inspection 814083 - 2012-12-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.